Description |
7,8-Dihydroxyflavone is a potent and selective TrkB agonist that mimics the physiological actions of Brain-derived neurotrophic factor (BDNF). Displays therapeutic efficacy toward various neurological diseases[1].
|
Target |
TrkB[1]
|
In Vitro |
7,8-Dihydroxyflavone (500 nM) protects the primary cortical neurons and locus coeruleus (LC) neurons from Aβ-induced toxicity and promotes dendritic growth and synaptogenesis[1].
|
In Vivo |
7,8-Dihydroxyflavone (5 mg/kg/day) prevents synaptic loss and memory deficits in a mouse model of Alzheimer’s Disease[1]. Administration of 7,8- dihydroxyflavone to mice activates TrkB in the brain, inhibits kainic acid-induced toxicity, decreases infarct volumes in stroke in a TrkBdependent manner, and is neuroprotective in an animal model of Parkinson disease[2].
|
Density | 1.4±0.1 g/cm3 |
Boiling Point | 494.4±45.0 °C at 760 mmHg |
Flash Point | 193.5±22.2 °C |
Exact Mass | 254.057907 |
PSA | 70.67000 |
LogP | 2.51 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Storage condition | Store at +4°C |